Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspective by Kishida, Ken et al.
PERSPECTIVE Open Access
Clinical significance of visceral fat reduction
through health education in preventing
atherosclerotic cardiovascular disease - Lesson
from the Amagasaki Visceral Fat Study:
A Japanese perspective
Ken Kishida
1,2*, Tohru Funahashi
1,2 and Iichiro Shimomura
2
Abstract
The metabolic syndrome has received worldwide recognition and is useful clinical aid in early-preventing
atherosclerosis. Visceral adiposity is the main component of the metabolic syndrome in Japan, based on ethnic
and racial difference in the pattern of adiposity. In the Amagasaki Visceral Fat Study, subjects had undergone
annual health check-ups and then received health education by medical personnel. Visceral fat reduction improved
hypoadiponectinemia and the number of obesity-related cardiovascular risk factors, and effectively prevented
cardiovascular events. The health education that includes voluntary lifestyle modification aimed at reducing visceral
fat could be useful in preventing cardiovascular events in the metabolic syndrome.
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Introduction
Adipocytes store excess energy as triglyceride, and also
function as part of the self-defense system against starva-
tion. Recent advances in research on adipocyte biology
have demonstrated that adipocytes synthesize and secrete
into the circulation various bioactive substances known as
adipocytokines, including angiogenic factors, cytokines,
complement factors and anti-diabetic, anti-atherogenic
factors, and adiponectin [1]. Masses of adipocytes, i.e., the
adipose tissue, exist in many areas of the human body, and
play important roles in angiogenesis, wound healing and
also act as a mechanical shock absorber. Visceral fat is a
specialized adipose tissue located in the mesentery and
omentum, and can provide fatty acids and glycerol to the
liver directly via the portal vein [2]. However, accumula-
tion of visceral fat exceeding the physiological range
results in adipocyte dysfunction. The imbalance in blood
levels of adipocytokines; i.e., overproduction of offensive
adipocytokines, such as tumor necrosis factor-alpha and
plasminogen activator inhibitor-1, and underproduction of
defensive adipocytokines such as adiponectin, disturbed
metabolism of free fatty acids, and fat-derived reactive
oxygen species, is the postulated molecular mechanism of
injury of arteries and various organs [2].
Obesity and lifestyle-related disorders
Obesity is an inevitable physical status in many coun-
tries worldwide where physical inactivity and over-eating
are common lifestyles, and has become the basis of var-
ious lifestyle-related disorders including impaired glu-
cose and lipid metabolism, hypertension, hyperuricemia,
chronic kidney disease, sleep apnea-hypopnea syndrome,
non-alcoholic steatohepatitis, and atherosclerotic cardio-
vascular diseases (ACVD). The increased incidence of
ACVD in working-age individuals is a worldwide health
problem, including East-Asians who have a smaller body
mass index compared to their counterparts in Western
countries. In Japanese, accumulation of intra-abdominal
visceral fat rather than absolute body fat mass seems to
be culprit of lifestyle-related disorders including the
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any medium, provided the original work is properly cited.metabolic syndrome [2]. In this regard, it is important to
define the relationship between visceral fat accumulation
and lifestyle-related disorders and also the significance
of weight reduction, particularly visceral fat reduction,
in large-scale general population.
The Amagasaki Visceral Fat Study
In the Amagasaki City Council (a city in Hyogo Prefec-
ture, Japan), several fatal ACVD events, i.e., stroke and
myocardial infarction, were recorded between 1994 and
2002 among the ~4,000 employees (Table 1). The insur-
ance and health costs of these events had also increased
during the same period. These data call for for programs
that can reduce the incidence of fatal ACVD events. In
Japan, health education based on the results of the
annual health checkups including measurement of visc-
eral adiposity was introduced in 2003 ahead of the
theme by the medical staff to prevent lifestyle-related
diseases including ACVD. Many people received dietary
advice, participated in physical activities and behavior
modification, designed to reduce visceral fat and the
number of risk factors. Subsequently, evaluation of visc-
eral adiposity, such as measurement of waist circumfer-
ence, and of visceral fat area, using visceral fat belt [3],
was added to the annual medical health check-up. Part
of such health education program is run by the public
health nurses, who provide the individual with scientific
information on the risk factors associated with visceral
fat accumulation (silent stage), clustering of multiple
risk factors (reversible stage), vascular damage (irreversi-
ble stage), and health problems including ACVD events
(irreversible and life-threatening stage) (Figure 1A).
Furthermore, the same nurses also explained the results
of the medical checkup and the relationship between
the subject’s lifestyle and the abnormalities recorded in
the health check-up, to promote voluntary lifestyle
changes. Voluntary lifestyle modification resulted in
reductions in accumulated visceral fat (reversible stage)
(Figure 1B) [4,5]. Another part of the health education
program included inviting the subjects to participate in
group discussions or one-to-one discussion with the
public health nurses. Subjects who required further
examination for ACVD or treatment of diabetes,
hypertension and/or dyslipidemia, were referred to the
family physicians or specialists for further management.
Our assessment indicates that this project, called
“Hokenshido” in Japanese, has already reduced the inci-
dence of fatal ACVD-related events in urban office
workers (Table 1). Health guidance “Hokenshido” is a
program that provides explanation to subjects at risk of
ACVD about their health condition for disease and
motivating them to alter their lifestyle, by public health
nurses, dieticians, and physicians when considered
necessary. Voluntary lifestyle modification is thus impor-
tant in the prevention of ACVD.
To understand how such project improved the out-
come, we conducted the Amagasaki Visceral Fat Study
based on visceral adiposity; a population-based cohort
study (UMIN 000002391) [3-12]. It is anticipated that
normalization of visceral fat mass through participation
in “Hokenshido” resulted in reductions in the incidence
of glucose tolerance, dyslipidemia, hypertension [5] and
hypoadiponectinemia [7], as well as the number of obe-
sity-related cardiovascular risk factors [4] and hence
help effectively prevent ACVD events [11]. Furthermore,
by reducing visceral fat mass, “Hokenshido” prevent
ACVD events in patients with the metabolic syndrome.
Admittedly, our assessment of the health promotion
program has certain limitati o n s .F i r s t ,t h es t u d yw a s
uncontrolled; i.e., was neither blind nor randomized,
and thus, there is a need for a more comprehensive and
thorough analysis. Second, we have not all data for non-
fatal ACVD events. Finally, in the present study, health
checkups were undergone mainly in every May-June.
Recent reports have demonstrated that seasonal varia-
tions exist within the metabolic syndrome parameters
[13-15]. Kamezaki et al. reported that seasonal variations
in the metabolic syndrome prevalence in Japanese male
workers [15]. The results indicate that the season of
health checkups may affect the clinical diagnosis and
management of the metabolic syndrome.
Conclusion
Visceral fat reduction by voluntary lifestyle modification
is an important strategy in the prevention of ACVD
events in the metabolic syndrome.
Table 1 Subjects’ numbers of fatal atherosclerotic cardiovascular disease events during year 1994-2008
ACVD deaths 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Myocardial infarction 2 1 1 2 1 1 2 0 0 0 0 0 1 0 0
Cerebrovascular disease 3 0 0 0 2 0 2 0 2 0 0 0 0 0 1
Total 5 1 1 2 3 1 4 0 2 0 0 0 1 0 1
Numbers of subjects.
A health promotion program directed against the metabolic syndrome was conducted in the Amagasaki municipal government offices, Hyogo prefecture, in
3,946 urban workers from Hyogo. The introduction of this program in year 2003 reduced the number of fatal atherosclerotic cardiovascular disease (ACVD)
events (deaths) in that population. Data from Kenko-Amagasakishi 21: Health Survey and Health Promotion Program for staff of the Amagasaki Municipal
Government office in 2004.
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